DNIB.com Reports Internet Has 368.4 Million Domain Name Registrations at the End of the First Quarter of 2025
Article content
Article content
Article content
RESTON, Va. — VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that, according to the latest Domain Name Industry Brief Quarterly Report from DNIB.com, the first quarter of 2025 closed with 368.4 million domain name registrations across all top-level domains (TLDs), an increase of 4.2 million domain name registrations, or 1.1%, compared to the fourth quarter of 2024. Domain name registrations also increased by 6.1 million, or 1.7%, year over year.
Article content
The .com and .net TLDs had a combined total of 169.8 million domain name registrations in the domain name base at the end of the first quarter of 2025, an increase of 0.8 million domain name registrations, or 0.5% compared to the fourth quarter of 2024. The .com and .net TLDs had a combined decrease of 2.6 million domain name registrations, or 1.5%, year over year. As of March 31, 2025, the .com domain name base totaled 157.2 million domain name registrations and the .net domain name base totaled 12.6 million domain name registrations. New .com and .net domain name registrations totaled 10.1 million at the end of the first quarter of 2025, compared to 9.5 million domain name registrations at the end of the first quarter of 2024.
Article content
Total country-code TLD (ccTLD) domain name registrations were 142.9 million at the end of the first quarter of 2025, an increase of 2.1 million domain name registrations, or 1.5% compared to the fourth quarter of 2024. ccTLDs increased by 3.4 million domain name registrations, or 2.4%, year over year. Available data is insufficient to estimate a combined quarterly renewal percentage across ccTLDs. The top 10 ccTLDs, as of March 31, 2025, were .cn, .de, .uk, .ru, .nl, .br, .au, .fr, .in and .eu.
Article content
DNIB.com, sponsored by Verisign, provides global statistical and analytical research and data on the domain name industry, plus analyses of key policy, security, and technology trends. The latest Domain Name Industry Brief Quarterly Report, previous reports, and interactive dashboards with expanded domain name industry data are all available at DNIB.com.
Article content
About Verisign
Article content
Verisign (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, enables internet navigation for many of the world's most recognized domain names. Verisign helps enable the security, stability, and resiliency of the Domain Name System and the internet by providing root zone maintainer services, operating two of the 13 global internet root servers, and providing registration services and authoritative resolution for the .com and .net top-level domains, which support the majority of global e-commerce. To learn more please visit verisign.com.
Article content
Article content
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Winnipeg Free Press
2 hours ago
- Winnipeg Free Press
S&P/TSX composite edges lower in late-morning trading, U.S. stocks mixed
TORONTO – Canada's main stock index edged lower in late-morning trading, weighed down by losses in the base metal and technology sectors, while U.S. stock markets were mixed. The S&P/TSX composite index was down 10.32 points at 26,365.48. In New York, the Dow Jones industrial average was down 11.02 points at 42,750.74. The S&P 500 index was up 1.56 points at 6,007.44, while the Nasdaq composite was down 8.57 points at 19,582.67. The Canadian dollar traded for 73.11 cents US compared with 73.08 cents US on Monday. The July crude oil contract was up 84 cents US at US$66.13 per barrel and the July natural gas contract was down eight cents US at US$3.55 per mmBTU. The August gold contract was down US$8.20 at US$3,346.70 an ounce and the July copper contract was down two cents US at US$4.91 a pound. Monday Mornings The latest local business news and a lookahead to the coming week. This report by The Canadian Press was first published June 10, 2025. Companies in this story: (TSX:GSPTSE, TSX:CADUSD)
Cision Canada
3 hours ago
- Cision Canada
Smart Healthcare Is Taking Over. Here's Where the Money's Headed
VANCOUVER, BC, June 10, 2025 /CNW/ -- Both politicians and leaders in academia are touting the AI revolution empowering the frontline of what's dubbed Smart Healthcare. In a recent write-up in Forbes, Prof. Nicos Savva of the London Business School cited recent speeches from former British Prime Minister Tony Blair, who insists that the UK needs to embrace a future with AI doctors and nurses, or risk being left behind. A new report from Wolters Kluwer has experts calling for more clarity around its use, adoption, and business strategy, because most healthcare organizations aren't currently ready to use GenAI tools. But as implementations increase across the sector, so too are major developments coming from innovators, including Avant Technologies, Inc. (OTCQB: AVAI), Renovaro Inc. (NASDAQ: RENB), Alphabet, Inc. (NASDAQ: GOOG) (NASDAQ: GOOGL), Omada Health, Inc. (NASDAQ: OMDA), and Inc. (NASDAQ: AMZN). McKinsey's Global Institute estimates Gen AI could unlock $60–110 billion in annual value across pharma and medical products alone. Statista now projects the global AI healthcare market will soar from $11 billion to $188 billion by 2030. Avant Technologies, Inc. (OTCQB: AVAI) has just taken a major step forward in its evolution from AI incubator to full-stack healthcare innovator. Today, the company announced it had signed a non-binding letter of intent to acquire 100% of Ainnova Tech, its joint venture partner and the developer of the Vision AI diagnostic platform. Prior to the acquisition, the two companies have been operating jointly through Ai-nova Acquisition Corp (AAC), which holds global licensing rights to Ainnova's technology portfolio and serves as the commercialization engine for Vision AI and all future device deployments. "We believe bringing the two companies together will offer tremendous value for shareholders, it will simplify the process of advancing our technology to market, and it will deliver value to our customers and partners as we promote our technology portfolio globally," said Vinicio Vargas, CEO at Ainnova and a member of the Board of Directors of AAC. "We feel the joint venture has been a success and both companies have worked well together toward a common goal, so we believe that we can be even more successful and use our resources more effectively as one company to further AI in healthcare." Under the proposed agreement, Ainnova would roll all of its outstanding equity into the combined public entity — unifying leadership and eliminating structural complexity ahead of a scheduled FDA pre-submission meeting in July. While final terms of the deal are still being negotiated, both companies say the merger would streamline commercialization and accelerate the rollout of Ainnova's flagship Vision AI technology — a platform already in use across clinical sites in Latin America for the early detection of diabetic retinopathy, cardiovascular disease, and other chronic conditions. The move also signals growing confidence from Avant's leadership as they prepare to bring proprietary hardware into the mix. In parallel with the merger discussions, Avant and Ainnova are entering the final prototyping stage of a low-cost, automated retinal imaging device — marking a potential turning point in the companies' shared push toward AI-powered early diagnostics. The new device is designed to operate hands-free and feed imaging data directly into the Vision AI platform, enabling near-instant risk reports without expensive equipment or trained personnel. The companies say the camera, developed under their joint venture Ai-nova Acquisition Corp. (AAC), is expected to cost a fraction of legacy fundus cameras. By combining affordability with automation, the device could expand screening access across primary care clinics and emerging-market providers that have traditionally been priced out of ophthalmic diagnostics. "The cost of a fundus camera has always been a barrier to entry in this market," said Vargas. "Our low-cost camera, which is a fraction of the cost of currently available cameras on the market, should allow us to not only enter the market, but to capture a large share of the market." Also in development are additional platform modules, including a patented dementia detection tool that combines a five-minute blood test with AI-trained algorithms. Although that technology remains in evaluation, the core platform continues to expand its reach and functionality — evolving from a retinal-focused application into a broader engine for predictive healthcare. "Our purpose is to create the future of early disease detection in an accessible way, so that patients can get a preventive check-up anywhere, at a low cost, and easily," said Vargas in a previous statement. "We want to prevent patients with risk factors from developing other diseases that could have been avoided before they became a real problem. To this end, we are seeking to integrate new technologies into our portfolio within a single platform, both through our R&D efforts and through potential exclusive licenses or acquisitions." As the camera prototype nears completion, Avant is positioning itself for broader market entry. While a launch date has yet to be announced, the integrated platform is designed to reduce diagnostic friction, speed up referrals, and expand access to early-stage health insights — especially in geographies where affordability, not innovation, remains the primary barrier to care. Renovaro Inc. (NASDAQ: RENB) recently announced a major expansion to its intellectual property portfolio with a newly approved U.S. patent for its AI-powered drug discovery and diagnostics infrastructure. "This patent is a strategic milestone for Renovaro," said David Weinstein, CEO of Renovaro. "Together with our previously granted patent, it forms the technological foundation of a scalable, end-to-end platform for AI-powered drug discovery and diagnostics and strengthens our position in the fast-growing market for data-driven therapeutics and clinical insights." The patent protects methods that harmonize genomic, imaging, clinical, and health record data into a standardized framework for large-scale predictive analytics. These capabilities are built for distributed computing environments, aligning with the biopharma industry's move toward real-time, scalable analytics. The development enhances Renovaro's competitive positioning in data-driven therapeutics and clinical insight markets. Alphabet, Inc. (NASDAQ: GOOG) (NASDAQ: GOOGL) recently showcased its leadership in AI-driven cancer research at the 2025 ASCO Annual Meeting, where Ruth Porat discussed Alphabet's evolving role in early diagnosis and treatment. "AI has greater potential than the internet, because it can augment human capabilities," wrote Ruth Porat, President & Chief Investment Officer of Alphabet and Google, quoting Vint Cerf. "It is a partner for all of you, for each of us." Porat highlighted Google's success with AlphaFold, which has accelerated cancer drug discovery by solving the decades-long problem of protein folding. She also noted the company's AI-assisted pathology tools that cut diagnostic time in half and improve detection of small metastases. From scalable diabetic retinopathy screening to generative AI for clinical workflows, she framed AI as a transformative force in healthcare delivery. Omada Health, Inc. (NASDAQ: OMDA) entered the public markets with a strong debut, raising $150 million and closing its first trading day 21% above IPO pricing. The company delivers AI-augmented virtual care for chronic conditions like diabetes, hypertension, and obesity, serving more than 679,000 active members. In May, prior to the IPO, Omada introduced Nutritional Intelligence, a new member experience powered by OmadaSpark—an AI agent that offers personalized, evidence-based nutrition coaching between clinical visits. As demand rises for GLP-1 medications, Omada is positioning its human-plus-AI model as essential to long-term metabolic health. "We believe there is a clear market need for real-time educational support backed by behavioral science to improve mindsets and behaviors toward food," said Wei-Li Shao, President at Omada Health. "To meet the needs of our customers and members, Omada fine tuned its approach to offer AI-powered tools trained with clinical input and expertise to work alongside human care teams in helping members drive improved health and economic outcomes." Inc. (NASDAQ: AMZN) continues to scale its digital health footprint via Amazon Web Services (AWS), which recently brought its HealthLake platform to the EU's Dublin Region. The move enables hospitals and insurers to unify siloed patient data using FHIR standards, while running AI-driven analytics and maintaining full data residency compliance. "I'm excited about AWS HealthLake launch in EU Region," said Ramon Postulart, CTO at Adapcare. " AWS HealthLake is a key AWS healthcare service helping us modernize interoperability across the 70+ care organizations and 60,000 health professionals we support in the Netherlands. By moving to this service, we're unlocking richer, standardized health data and leveraging the HealthLake fully managed capabilities to build smarter, AI-powered tools for care planning and coordination." HealthLake now serves as the engine behind personalized care tools in development across Ireland, the Netherlands, and Finland. AWS also hosted its Health Data & AI Day in Dublin to promote cross-border health data innovation and the European Health Data Space initiative. DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Equity Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc. ("MIQ"). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased in the open market. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
Cision Canada
5 hours ago
- Cision Canada
Cisco Unveils Secure Network Architecture to Accelerate Workplace AI Transformation
Radically simplifies network operations, delivers exponential performance with next-generation devices and fuses security into the network Cisco's new secure network architecture addresses the urgent challenges for enterprises in the AI era: explosive network traffic, mission-critical uptime requirements, and intensifying security threats. New AI-powered management capabilities, next-gen high-capacity and low-latency network devices, and a quantum-resistant security model simplify complex IT and OT operations and enhance workforce productivity. Cisco's unified management platform manages the AI-ready network securely and with simplicity, empowering enterprises to confidently adopt and scale AI solutions, giving them a competitive edge. SAN DIEGO, June 10, 2025 /CNW/ -- CISCO LIVE -- Cisco (NASDAQ: CSCO) today unveiled a new network architecture to power the campus, branch, and industrial networks of the future. The new architecture delivers unmatched operational simplicity through unified management, next-generation networking devices purpose-built for AI workloads, and advanced security capabilities embedded into the network. Cisco is setting a new standard for how organizations navigate the challenges of skyrocketing traffic, rising cyber threats, and critical uptime requirements created as enterprises rush to harness the potential of AI in the workplace. According to the Cisco IT Networking Leader Survey, 97% of businesses believe they need to upgrade their networks to make AI and IoT initiatives successful, and the stakes are high: a single severe outage can inflict nearly $160 billion in losses globally. Faced with these challenges, IT teams need a new approach to scale operations, reduce downtime, and unlock new levels of efficiency and innovation. "As AI transforms work, it fuels explosive traffic growth across campus, branch, and industrial networks, overwhelming IT teams with complexity and novel security risks at a time when downtime has never been more costly," said Jeetu Patel, President and Chief Product Officer, Cisco. "With a new architecture, breakthrough devices optimized for AI, and AgenticOps, we're leapfrogging the industry and reimagining how networks are managed and secured." Simplifying Operations with Unified Management and AgenticOps Operational complexity is among the greatest challenges facing IT teams today. Cisco's unified management platform addresses this by bringing together management of Meraki and Catalyst devices, along with support for next-gen wireless, switching, routing, and industrial networks—all in a single platform that supports any cloud, on-prem, or hybrid deployment. Cisco's unified management platform is further differentiated by ThousandEyes assurance —which now extends to mobile endpoints, and industrial IoT—and delivers deeper, more actionable visibility into enterprise networks and Microsoft Azure. A new ThousandEyes and Splunk integration adds real-time insights from network to application. This multilayered approach delivers comprehensive assurance and observability across both owned and unowned infrastructure, helping ensure consistent performance and operational resilience. Supercharging the platform is AgenticOps, Cisco's AI-driven approach to running modern IT operations that turns real-time telemetry, automation, and deep domain expertise into intelligent, end-to-end actions —at machine speed and with IT teams still in control. Cisco's AgenticOps capabilities are powered by a new Deep Network Model — a domain-specific LLM trained on decades of Cisco expertise, from CCIE-level content to Cisco U. courseware. The Deep Network Model also powers the Cisco AI Assistant, a natural language interface that identifies issues, diagnoses root causes, and automates workflows. The result is AI that understands networks and works the way IT does, reducing task time from hours to minutes. Also, Cisco is introducing the all-new AI Canvas, a new AgenticOps capability, a generative AI user interface for customer dashboards that enables NetOps, SecOps, and DevOps teams to collaborate, optimize operations, and reduce IT strain. Next-Gen Network Devices Designed to Scale for AI To meet the unprecedented demands AI workloads will place on networks, Cisco is unveiling purpose-built hardware that delivers low latency, high capacity, and robust security for the AI-powered enterprise. Each device is tailored to meet the specific demands of its environment: New Cisco C9350 and C9610 Smart Switches to Power Campus Networks: Cisco is launching a new generation of Cisco Smart Switches, powered by Silicon One, that delivers up to 51.2Tbps of throughput, below 5 microsecond latency and quantum-resistant secure networking to power high-stakes AI applications. New Cisco 8100, 8200, 8300, 8400 and 8500 Secure Routers: As AI transforms branch operations and customer interactions, new Cisco Secure Routers offer native SD-WAN and Secure Access Service Edge (SASE) integration, next-generation firewall (NGFW), and post-quantum security into a single-box WAN solution—with up to three times the throughput of previous generations. Expanded Wireless Portfolio: Cisco is extending its Wi-Fi 7 portfolio with the Cisco Wireless 9179F Series Access Points for stadiums and large venues, and is delivering seamless, cloud-managed roaming for large campuses with the new Cisco Campus Gateway. Expanded Industrial Portfolio: To meet the rigorous performance and reliability demands of industrial AI use cases, Cisco is introducing new ruggedized switches in a variety of form factors to support applications including visual quality inspections and autonomous mobile robots. Additionally, new critical wireless use cases are now connected with the integration of Ultra-Reliable Wireless Backhaul (URWB) together with Wi-Fi technology in a single access point. Security Integrated Seamlessly into the Network Today's enterprise networks face a complex and dynamic security landscape. To combat these continually evolving threats, Cisco is integrating advanced security seamlessly into the network, and is unveiling new protections across three critical layers: Securing Network Infrastructure: New Cisco Live Protect provides kernel-level compensating controls, block exploits and defend campus switches and routers — without requiring reimaging or downtime. Defending Data in Transit: To safeguard data in transit, Cisco has added post-quantum-ready MACsec, WAN MACsec, and IPsec encryption to defend against "harvest-now, decrypt-later" attacks. In addition, the new Cisco C9000 Smart Switches are Hypershield -ready. This will help enhance network segmentation to contain threats at machine speed. Protecting Users, Endpoints, and Applications: Starting from a strong foundation of microsegmentation, AI-powered device classification, and common policy, Cisco is extending protections for every device and application connected across the network. With intelligence from Cisco Identity Services Engine, Cyber Vision, and Cisco Talos combined with Cisco Secure Access SSE, organizations can enforce security effectively at every point in the network. "Organizations are at a critical juncture. The promise of AI is immense, but the reality is that existing enterprise networks are simply not equipped to handle the scale, security, and reliability requirements that AI demands," said Matt Eastwood, IDC. "Cisco's new secure network architecture marks a critical evolution in networking and provides a future-ready foundation for enterprises to confidently embrace AI without sacrificing performance or security." Availability With hardware orderable this month through Cisco or Cisco certified partners, this new architecture is powered by a single platform, with unified management, licensing and support, and the flexibility to deploy in the cloud, hybrid, or on-premises. The unified management platform is available now, Cisco AI Assistant is in public beta, and Cisco AI Canvas will be tested with select customers this fall. Additional Resources: Visit the Cisco Newsroom for all Cisco Live 2025 announcements. Cisco Customer Experience helps customers get more from their technology investments. Cisco Capital payment solutions provide choices – ways to pay for your technology in more than 100 countries. Support AI-ready outcomes with new skills training in Cisco U. About Cisco Cisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco has securely connected the world. With its industry leading AI-powered solutions and services, Cisco enables its customers, partners and communities to unlock innovation, enhance productivity and strengthen digital resilience. With purpose at its core, Cisco remains committed to creating a more connected and inclusive future for all. Discover more on The Newsroom and follow us on X at @Cisco. Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco's trademarks can be found at Third-party trademarks mentioned are the property of their respective owners. The use of the word 'partner' does not imply a partnership relationship between Cisco and any other company. Disclaimer: Many of the products and features mentioned are still in development and will be made available as they are finalized, subject to ongoing evolution in development and innovation. The timeline for their release is subject to change.
